What is he best known for?
The fields of study he is best known for:
- Gene
- Neuron
- Internal medicine
Alexei Verkhratsky mainly investigates Neuroscience, Cell biology, Neurotransmission, Central nervous system and Astrocyte.
The concepts of his Neuroscience study are interwoven with issues in Disease, Neurodegeneration, Microglia and Homeostasis.
His Neuroinflammation research extends to Microglia, which is thematically connected.
He combines subjects such as Brain function, Innate immune system, Pattern recognition receptor, Immunity and Systemic inflammation with his study of Neuroinflammation.
His Neurotransmission research incorporates themes from Glutamate receptor, Synapse, Neurotransmitter and Synaptic plasticity.
Alexei Verkhratsky focuses mostly in the field of Central nervous system, narrowing it down to topics relating to Nervous system and, in certain cases, Synaptogenesis.
His most cited work include:
- Neuroinflammation in Alzheimer's disease (2213 citations)
- Neuroinflammation in Alzheimer's disease (2213 citations)
- Neuroinflammation in Alzheimer's disease (2213 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Neuroscience, Cell biology, Astrocyte, Internal medicine and Neuroglia.
His Neuroscience research is mostly focused on the topic Central nervous system.
The various areas that he examines in his Cell biology study include Exocytosis and Receptor.
His work deals with themes such as Glutamate receptor and Astrogliosis, which intersect with Astrocyte.
In his study, Ryanodine receptor is inextricably linked to Endocrinology, which falls within the broad field of Internal medicine.
His work carried out in the field of Microglia brings together such families of science as Neuroinflammation and Immune system.
He most often published in these fields:
- Neuroscience (80.22%)
- Cell biology (49.61%)
- Astrocyte (41.29%)
What were the highlights of his more recent work (between 2019-2021)?
- Neuroscience (80.22%)
- Astrocyte (41.29%)
- Cell biology (49.61%)
In recent papers he was focusing on the following fields of study:
Alexei Verkhratsky spends much of his time researching Neuroscience, Astrocyte, Cell biology, Central nervous system and Glutamate receptor.
His Neuroscience study combines topics in areas such as Synaptic plasticity, Neurodegeneration, Disease, Microglia and Purinergic signalling.
His Microglia study integrates concerns from other disciplines, such as Bipolar disorder, Neuroinflammation, Mood disorders and Neuroglia.
His biological study spans a wide range of topics, including Synaptogenesis, Neurotransmission and Nervous system.
His Cell biology research is multidisciplinary, incorporating perspectives in Exocytosis and Blood–brain barrier.
He has included themes like Antidepressant, Homeostasis, Fluoxetine, Serotonin and Major depressive disorder in his Central nervous system study.
Between 2019 and 2021, his most popular works were:
- Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. (118 citations)
- Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. (118 citations)
- Reactive astrocyte nomenclature, definitions, and future directions (28 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Neuron
- Internal medicine
His main research concerns Astrocyte, Neuroscience, Glutamate receptor, Homeostasis and Neurotransmission.
His Astrocyte study deals with the bigger picture of Central nervous system.
His Central nervous system research is multidisciplinary, relying on both Neurogenesis and Aquaporin 4.
His Neuroscience research includes elements of Neuroinflammation and Purinergic signalling.
His Homeostasis study improves the overall literature in Cell biology.
His Neurotransmission research integrates issues from Transporter, Calcium, Stimulation, Intracellular and Na+/K+-ATPase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
